388 related articles for article (PubMed ID: 36419143)
21. Treatment of Mycobacterium abscessus Pulmonary Disease.
Griffith DE; Daley CL
Chest; 2022 Jan; 161(1):64-75. PubMed ID: 34314673
[TBL] [Abstract][Full Text] [Related]
22. Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus.
Bax HI; de Vogel CP; Mouton JW; de Steenwinkel JEM
J Antimicrob Chemother; 2019 Oct; 74(10):2930-2933. PubMed ID: 31236595
[TBL] [Abstract][Full Text] [Related]
23. Advances in the management of pulmonary disease due to Mycobacterium abscessus complex.
Koh WJ; Stout JE; Yew WW
Int J Tuberc Lung Dis; 2014 Oct; 18(10):1141-8. PubMed ID: 25216826
[TBL] [Abstract][Full Text] [Related]
24. The treatment of rapidly growing mycobacterial infections.
Kasperbauer SH; De Groote MA
Clin Chest Med; 2015 Mar; 36(1):67-78. PubMed ID: 25676520
[TBL] [Abstract][Full Text] [Related]
25. Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease.
Singh S; Wang JY; Heysell SK; McShane PJ; Wadle C; Shankar P; Huang HL; Pasipanodya J; Boorgula GD; Philley JV; Gumbo T; Srivastava S
Int J Antimicrob Agents; 2023 Jul; 62(1):106847. PubMed ID: 37187338
[TBL] [Abstract][Full Text] [Related]
26. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
[No Abstract] [Full Text] [Related]
27. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
[TBL] [Abstract][Full Text] [Related]
28. Species identification and drug susceptibility testing of non-tuberculous mycobacteria by Line Probe Assay in Lambaréné, Gabon-a cross-sectional study.
Ndanga MED; Abdul JBPAA; Edoa JR; Ibinda GARM; Adegbite BR; Mevyann RC; Biyogho CM; Mahoumbou J; Manguinga S; Roguet NM; Lell B; Kremsner PG; Alabi AS; Grobusch MP; Adegnika AA
BMC Infect Dis; 2023 Oct; 23(1):651. PubMed ID: 37789292
[TBL] [Abstract][Full Text] [Related]
29. Molecular Epidemiological Characteristics of Mycobacterium abscessus Complex Derived from Non-Cystic Fibrosis Patients in Japan and Taiwan.
Yoshida M; Chien JY; Morimoto K; Kinjo T; Aono A; Murase Y; Fujiwara K; Morishige Y; Nagano H; Jou R; Hasegawa N; Ato M; Hoshino Y; Hsueh PR; Mitarai S
Microbiol Spectr; 2022 Jun; 10(3):e0057122. PubMed ID: 35446117
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
Lee MC; Sun PL; Wu TL; Wang LH; Yang CH; Chung WH; Kuo AJ; Liu TP; Lu JJ; Chiu CH; Lai HC; Chen NY; Yang JH; Wu TS
J Antimicrob Chemother; 2017 Oct; 72(10):2782-2786. PubMed ID: 29091186
[TBL] [Abstract][Full Text] [Related]
31. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR
J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068
[TBL] [Abstract][Full Text] [Related]
32. Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice.
Aragaw WW; Roubert C; Fontaine E; Lagrange S; Zimmerman MD; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0140021. PubMed ID: 34723632
[TBL] [Abstract][Full Text] [Related]
33. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus.
Johansen MD; Herrmann JL; Kremer L
Nat Rev Microbiol; 2020 Jul; 18(7):392-407. PubMed ID: 32086501
[TBL] [Abstract][Full Text] [Related]
34. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
[TBL] [Abstract][Full Text] [Related]
35. In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United States.
Hunkins JJ; de-Moura VC; Eddy JJ; Daley CL; Khare R
Diagn Microbiol Infect Dis; 2023 Mar; 105(3):115882. PubMed ID: 36610383
[TBL] [Abstract][Full Text] [Related]
36. Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes.
El Ghali A; Morrisette T; Alosaimy S; Lucas K; Tupayachi-Ortiz MG; Vemula R; Wadle C; Philley JV; Mejia-Chew C; Hamad Y; Stevens RW; Zeuli JD; Webb AJ; Fiske CT; Simonyan A; Cimino CL; Mammadova M; Umana VE; Hasbun R; Butt S; Molina KC; Thomas M; Kaip EA; Bouchard J; Gore TW; Howard C; Cabanilla MG; Holger DJ; Frens JJ; Barger M; Ong A; Cohen KA; Rybak MJ
Antimicrob Agents Chemother; 2023 Oct; 67(10):e0082423. PubMed ID: 37768312
[TBL] [Abstract][Full Text] [Related]
37. Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report.
Kim SY; Shin SJ; Jeong BH; Koh WJ
BMC Infect Dis; 2016 May; 16():207. PubMed ID: 27188784
[TBL] [Abstract][Full Text] [Related]
38. The Use of Comparative Genomic Analysis for the Development of Subspecies-Specific PCR Assays for
Akwani WC; van Vliet AHM; Joel JO; Andres S; Diricks M; Maurer FP; Chambers MA; Hingley-Wilson SM
Front Cell Infect Microbiol; 2022; 12():816615. PubMed ID: 35419298
[No Abstract] [Full Text] [Related]
39. Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens.
Cho EH; Huh HJ; Song DJ; Lee SH; Kim CK; Shin SY; Ki CS; Jhun BW; Moon SM; Kwon OJ; Koh WJ; Lee NY
Diagn Microbiol Infect Dis; 2019 Feb; 93(2):107-111. PubMed ID: 30236529
[TBL] [Abstract][Full Text] [Related]
40.
Shoen C; Benaroch D; Sklaney M; Cynamon M
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
